Amrita Institute of Medical Sciences, also referred to as Amrita Hospital, is a super-specialty quaternary care health center and medical school in Kochi, India. It is one of the largest medical facilities in the country with a total built-up area of over 3.33 million sq.ft, spread over 125 acres of land.

There are 1,450 beds in Amrita Institute of Medical Sciences.

During the past decade, Amrita Institute of Medical Sciences conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Amrita Institute of Medical Sciences" #1 sponsor was "Amrita Institute of Medical Sciences & Research Center" with 2 trials, followed by "Bayer" with 2 trials sponsored, "CymaBay Therapeutics, Inc." with 2 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored and "AtheroGenics" with 1 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Amrita Institute of Medical Sciences" #1 collaborator was "Aalborg University Hospital" with 1 trials as a collaborator, "Aarhus University Hospital" with 1 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Aga Khan University" with 1 trials as a collaborator and "All India Institute of Medical Sciences, New Delhi" with 1 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Amrita Institute of Medical Sciences" are "Type 2 Diabetes Mellitus" (2 trials), "Acute-On-Chronic Liver Failure" (1 trials), "Adenocarcinoma of the Esophagus" (1 trials), "Arthralgia" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Amrita Institute of Medical Sciences" in a lesser frequency.

Most popular intervention types in "Amrita Institute of Medical Sciences" are "Drug" (23 trials), "Other" (6 trials), "Procedure" (3 trials), "Radiation" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Actos" (2 trials), "Darolutamide (Nubeqa, BAY1841788)" (2 trials), "MBX-102" (2 trials) and "131I-chTNT-1/B MAb (Cotara)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Amrita Institute of Medical Sciences" are 30 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Amrita Institute of Medical Sciences". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Amrita Institute of Medical Sciences, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Amrita Institute of Medical Sciences, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".